Rôle Des Colliculi inférieurs Dans Les Hallucinations Auditives : étude Pilote Par Neuroimagerie

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The neural basis of auditory hallucinations (AH) in patients with schizophrenia is poorly characterized. Functional imaging studies investigate either the state dimension (i.e., the measurement of changes in brain area activation at the precise moment of AH onset) or the trait dimension (i.e., the neural correlates of the propensity to hallucinate). A corollary of AH (particularly acoustic-verbal) is the activation of brain regions involved in the auditory perception of speech (auditory cortex). One theory is that patients with schizophrenia with AH may have a deficit in processing their internal speech (i.e., external attribution to internal verbal content). However, there is little clinical data on the specific role of the mesencephalic region of the inferior colliculi (IC) in the formation of these symptoms. Preliminary research has shown intense expression of dopamine D2 receptors, particularly on glutamatergic neurons in mouse ICs. Thus, ICs receive numerous inhibitory dopaminergic inputs, likely involved in signal optimization and modulation. The study authors hypothesize that AHs are the result of a defect in signal inhibition by the IC, which lose their function as perceptual filters.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 60
Healthy Volunteers: f
View:

• The patient must have given their free and informed consent and signed the consent form

• The patient must be a member or beneficiary of a health insurance plan

• DSM-5 diagnosis of schizophrenic disorder (based on clinical assessment and confirmed by the MINI 7.0 interview)

• Patient with a schizophrenic disorder lasting ≤ 20 years

• Patient treated in a psychiatric unit as an inpatient (in non-specialized care) or outpatient or under a mandatory ambulatory psychiatric care programme

• Clinical condition compatible with imaging based on clinical judgment

• Ability to understand, write, and read French

⁃ • Patient with a PANSS score (question P3 regarding hallucinations) = 1) AND having not experienced any hallucinations in the past 15 days.

Locations
Other Locations
France
CHU de Nîmes, Hôpital Universitaire Carémeau
RECRUITING
Nîmes
Contact Information
Primary
Martin Pastre
matinpastre@gmail.com
06 95 55 68 80
Time Frame
Start Date: 2025-09-12
Estimated Completion Date: 2026-09
Participants
Target number of participants: 40
Treatments
Experimental: Patient Group (SCZ+/AH+)
schizophrenic patients experiencing auditory hallucinations
Experimental: Control Group (SCZ+/AH-)
schizophrenic patients without hallucinations
Related Therapeutic Areas
Sponsors
Leads: Centre Hospitalier Universitaire de Nīmes

This content was sourced from clinicaltrials.gov